Journal of Psychosomatic Research
Volume 68, Issue 2 , Pages 149-158 , February 2010

Joint effect of self-reported sleep problems and three components of the metabolic syndrome on risk of coronary heart disease

  • Minna Loponen

      Affiliations

    • University of Tampere, Tampere School of Public Health, Tampere, Finland
    • Helsinki Heart Study, Helsinki, Finland
    • Corresponding Author InformationCorresponding author. Helsinki Heart Study, Kalliolinnantie 4, 00140 Helsinki, Finland. Tel.: +358 9 191 24074; fax: +358 9 191 24074.
    • ,
  • Christer Hublin

      Affiliations

    • Finnish Institute of Occupational Health, Finland
    • ,
  • Raija Kalimo

      Affiliations

    • Finnish Institute of Occupational Health, Finland
    • ,
  • Matti Mänttäri

      Affiliations

    • Helsinki University Jorvi Hospital, Espoo, Finland
    • Wihuri Research Institute, Helsinki, Finland
    • ,
  • Leena Tenkanen

      Affiliations

    • University of Tampere, Tampere School of Public Health, Tampere, Finland
    • Helsinki Heart Study, Helsinki, Finland

Received 23 January 2009 ,Revised 20 July 2009 ,Accepted 21 July 2009.

References 

  1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111
  2. Soldatos CR, Allaert FA, Ohta T, et al. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine. 2005;6:5–13
  3. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manag Care. 2006;12:214–220
  4. Wolk R, Gami AS, Garcia-Touchard A, et al. Sleep and cardiovascular disease. Curr Probl Cardiol. 2005;30:625–662
  5. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118:1080–1111
  6. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II Cohort. Sleep. 2007;30:1659–1666
  7. Hublin C, Partinen M, Koskenvuo M, et al. Sleep and mortality: a population-based 22-year follow-up study. Sleep. 2007;30:1245–1253
  8. Elwood P, Hack M, Pickering J, et al. Sleep problem, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. 2006;60:69–73
  9. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053
  10. Schenck CH, Mahowald MW, Sack RL. Assessment and management of insomnia. JAMA. 2003;289:2475–2479
  11. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 1999;22:386–393
  12. Fry J, Finley W. The prevalence and costs of obesity in the EU. Proc Nutr Soc. 2005;64:359–362
  13. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–1209
  14. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  15. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the national Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004;109:433–438
  16. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–636
  17. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007;82:509–524
  18. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006;47:1093–1100
  19. Wolk R, Somers VK. Sleep and metabolic syndrome. Exp physiol. 2007;92:67–78
  20. Choi KM, Lee JS, Park HS, et al. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes. 2008;32:1091–1097
  21. Hall MH, Muldoon MF, Jennings JR, et al. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008;3:635–643
  22. Jennings JR, Muldoon MF, Hall M, et al. Self-reported sleep quality is associated with the metabolic syndrome. Sleep. 2007;30:219–223
  23. Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007;11:163–178
  24. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–741
  25. Bjorvatn B, Sagen I, Øyane N, et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res. 2007;16:66–76
  26. Vorona RD, Winn MP, Babineau TW, et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 2005;165:25–30
  27. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey. Hypertension. 2006;47:833–839
  28. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999;84:2603–2607
  29. Grundy SM. Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92:399–404
  30. Liu J, Grundy SM, Wang W, et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007;153:552–558
  31. Kalimo R, Tenkanen L, Härmä M, et al. Job stress and sleep disorders: findings from the Helsinki Heart Study. Stress Med. 2000;16:65–75
  32. Tenkanen L, Mänttäri M, Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation. 1995;92:1779–1785
  33. Pietilä K, Tenkanen L, Mänttäri M, et al. How to define coronary heart disease in register-based follow-up studies: experience from the Helsinki Heart Study. Ann Med. 1997;29:253–259
  34. Kleitman N. Sleep and Wakefulness. Chicago: University of Chicago Press; 1963;
  35. Frick MH, Elo O, Haapa K, et al. The Helsinki Heart Study: primary prevention trial with gemfibrozil middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237–1245
  36. Sateia M, Nowell P. Insomnia. Lancet. 2004;364:1959–1973
  37. Ohayon M. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev. 2008;12:129–141
  38. Summers M, Crisostomo M, Stepanski E. Recent developments in the classification, evaluation, and treatment of insomnia. Chest. 2006;130:276–286
  39. Phillips M, Mannino D. Does insomnia kill?. Sleep. 2005;28:965–971
  40. Hublin C, Kaprio M, Partinen M, et al. Daytime sleepiness in an adult, Finnish population. J Intern Med. 1996;239:417–423
  41. Ohayon M, Partinen M. Insomnia and global dissatisfaction in Finland. J Sleep Res. 2002;11:339–346
  42. Hublin C, Kaprio J, Partinen M, et al. Insufficient sleep—a population-based study in adults. Sleep. 2001;24:392–400
  43. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1:210–217
  44. Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ. 2007;33:475–482
  45. Kraja A, Province M, Arnett D, et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?. Nutr Metab. 2007;4:28
  46. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation. 2000;101:252–257
  47. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–1439
  48. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43:678–683
  49. von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131:733–739
  50. Manninen V, Huttunen JK, Tenkanen L, et al. High density lipoprotein cholesterol as a risk factor for coronary heart disease in the Helsinki Heart Study. In:  Miller NE editors. High-density lipoproteins, reverse cholesterol transport, and coronary heart disease. Excerpta Medica; 1989;p. 76–84

☆ This work was supported by a grant from the Pirkanmaa Regional Fund of the Finnish Cultural Foundation.

PII: S0022-3999(09)00281-5

doi: 10.1016/j.jpsychores.2009.07.022

Journal of Psychosomatic Research
Volume 68, Issue 2 , Pages 149-158 , February 2010

Article Tools

* Image Usage & Resolution